WHO ICTRP trial
Optimization of diagnosis and treatment plan for idiopathic membranous…
ITMCTR2200006126 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2200006126 |
|---|---|
| Public title | Optimization of diagnosis and treatment plan for idiopathic membranous nephropathy in the integrative medicine |
| Scientific title | Optimization of diagnosis and treatment plan for idiopathic membranous nephropathy in the integrative medicine |
| Primary sponsor | Shanxi Hospital of Traditional Chinese Medicine |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Idiopathic Membranous Nephropathy |
| Interventions | blood stasis:Qilong Tongshen Granules;humid stasis type:Fenqinghuazhuo capsules |
| Registration date | Jun 14, 2022 |
| Target size | blood stasis:60;humid stasis type:60 |
| Secondary IDs | ChiCTR2200060951;ChiMCTR2200006126 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: